DIRS.INFO The most relevant business & tech news

Genius, formerly known as Rap Genius, maintains a vast database of song lyrics. "We license lyrics on Google Search from third parties, and we do not crawl or scrape websites to source lyrics," Castaneda added. The Genius lawsuit stated that one of the first Google posts it suspected as copying involved the lyrics for the song "Panda" by the rapper Desiigner. "I got broads in Atlanta," part of the song's lyrics read. Genius said in its appeal to the Supreme Court that the 2nd Circuit's ruling would give "behemoths like Google" a free pass to "vacuum up content and increase their internet dominance."

Persons: Alphabet's, Genius, Jose Castaneda, " Castaneda, Hittin, bando, Kendrick Lamar, Selena Gomez, Alessia Cara, Joe Biden's, Blake Brittain, Will Dunham Organizations: WASHINGTON, U.S, Supreme, Alphabet's Google, Google, eBay, Genius, The, Circuit, Thomson Locations: New York, Atlanta, The New York, Washington

☆ Fowler leads midway through U.S. Open first round
▼ + stars: | 2023-06-15 | by ( ) www.reuters.com time to read: +1 min

LOS ANGELES, June 15 (Reuters) - American Rickie Fowler held the early lead at the U.S. Open on Thursday with Xander Schauffele in a group one shot back and Masters champion Jon Rahm four adrift midway through his first round at the Los Angeles Country Club. Fowler, runner-up in 2014, started on the back nine and produced six birdies and two bogeys through his first 10 holes. The 123rd U.S Open got underway against the backdrop of the bombshell announcement of a partnership between the PGA Tour, DP World Tour and the Saudi backers of the LIV circuit. Defending champion Matt Fitzpatrick is in a group with last year's British Open winner Cameron Smith, one of the breakaway tour's biggest recruits. One of the morning's biggest attractions was an all-American grouping of world number one Scottie Scheffler with twice major champion Collin Morikawa and home favourite Max Homa.

Persons: Rickie Fowler, Xander Schauffele, Jon Rahm, Fowler, Rahm, Rory McIlroy, LIV, LIV Golf's Brooks Koepka, Matt Fitzpatrick, Cameron Smith, Scottie Scheffler, Collin Morikawa, Max Homa, Scheffler, Amy Tennery, Toby Davis, Ed Osmond Organizations: U.S, Los Angeles Country Club, 123rd U.S, PGA, Saudi, Thomson Locations: ANGELES, Saudi, British, Homa, New York

May 18 (Reuters) - The U.S. Senate is expected to vote Thursday on whether to confirm President Joe Biden's nominee to a federal appeals court a day after Senator Joe Manchin became the first one of Biden's fellow Democrats to vote against one of his judicial picks. Her confirmation faced a new obstacle on Wednesday night when Manchin, a moderate Democrat, broke ranks to oppose advancing her nomination. Her nomination advanced Wednesday on a 50-48 vote after two Republican senators did not participate, teeing it up for final consideration by the full Senate. If Manchin again opposes Abudu during the final vote on her confirmation, Vice President Kamala Harris could be called in to break a tie. That court flipped to a majority of Republican-appointed judges under then-President Donald Trump, who picked six of the 11 active judges.

WASHINGTON, May 18 (Reuters) - The U.S. Supreme Court on Thursday ruled against Amgen Inc (AMGN.O) in its bid to revive patents on its cholesterol-lowering drug Repatha over a legal challenge by French rival Sanofi SA (SASY.PA). Amgen sought to patent a group of antibodies that help reduce so-called "bad" cholesterol. In 2014, Amgen sued Sanofi and Regeneron for patent infringement over their rival drug Praluent, which works by a similar mechanism as Repatha. The justices said that Supreme Court precedent weighed against Amgen. President Joe Biden's administration, arguing in support of Sanofi, told the justices that Amgen had not disclosed the information needed to make to make its patents valid.

May 17 (Reuters) - Federal appeals court judges appeared to express support on Wednesday for opponents of the abortion pill mifepristone to pursue their challenge to its U.S. approval, which has potentially far-reaching consequences for abortion access across the country. Circuit Court of Appeals in New Orleans to overturn last month's unprecedented ruling by U.S. District Judge Matthew Kacsmaryk in Amarillo, Texas suspending mifepristone's approval. [1/2] A patient prepares to take Mifepristone, the first medication in a medical abortion, at Alamo Women's Clinic in Carbondale, Illinois, U.S., April 20, 2023. Circuit Judges James Ho and Wilson were appointed by Donald Trump. SAFE AND EFFECTIVEMifepristone remains available for now, following an emergency order from the U.S. Supreme Court putting Kacsmaryk's order on hold during the appeal.

[1/2] A patient prepares to take Mifepristone, the first medication in a medical abortion, at Alamo Women's Clinic in Carbondale, Illinois, U.S., April 20, 2023. REUTERS/Evelyn Hockstein/File PhotoMay 17 (Reuters) - U.S. appeals court judges began hearing arguments on Wednesday in a legal battle over the availability of the abortion pill mifepristone, with potentially far-reaching consequences for abortion access across the United States. Circuit Court of Appeals in New Orleans to overturn last month's unprecedented ruling by U.S. District Judge Matthew Kacsmaryk in Amarillo, Texas suspending mifepristone's approval. Danco Laboratories, which sells the drug under the brand name Mifeprex, is also expected to argue before the court. The emergency room doctors said they were being forced to complete surgical abortions, which was against their conscience, for women who took the pill and failed to complete a medical abortion.

[1/2] A patient prepares to take Mifepristone, the first medication in a medical abortion, at Alamo Women's Clinic in Carbondale, Illinois, U.S., April 20, 2023. REUTERS/Evelyn Hockstein/File PhotoMay 17 (Reuters) - A federal appeals court in New Orleans will hear arguments on Wednesday in a closely watched case brought by anti-abortion activists seeking to ban the abortion pill mifepristone, with potentially far-reaching impact on abortion access across the United States. Circuit Court of Appeals to overturn last month's unprecedented ruling by U.S. District Judge Matthew Kacsmaryk in Amarillo, Texas suspending mifepristone's FDA approval. Mifepristone remains available for now, following an emergency order from the U.S. Supreme Court putting Kacsmaryk's order on hold during the appeal. Whichever way the 5th Circuit panel rules, the decision is sure to be appealed, first to the full court and then to the U.S. Supreme Court.

☆ New York Attorney General Letitia James leads multistate effort defending CFPB to the Supreme Court
▼ + stars: | 2023-05-16 | by ( Chelsey Cox | ) www.cnbc.com time to read: +2 min

WASHINGTON — New York Attorney General Letitia James is leading a multistate effort to urge the Supreme Court to overturn a decision that threatens the existence of the nation's leading consumer protection agency. Attorneys general in 22 other states and the District of Columbia joined New York in an amicus brief filing to the court Tuesday in support of the Consumer Financial Protection Bureau. The brief comes a day after dozens of current and former Democratic lawmakers filed a separate amicus brief defending the agency. The Supreme Court agreed in February to hear arguments after the Biden administration appealed the U.S. 5th Circuit Court of Appeals' decision that the CFPB's funding method is unconstitutional. If the Supreme Court decides not to overturn the 5th Circuit's ruling, it could invalidate "numerous CFPB rules and other regulatory actions" and harm millions of Americans while destabilizing the consumer financial sector, the attorneys general said in a statement.

☆ Dozens of Democrats defend CFPB at Supreme Court as case threatens its existence
▼ + stars: | 2023-05-15 | by ( Chelsey Cox | ) www.cnbc.com time to read: +2 min

WASHINGTON — Over 140 current and former Democratic lawmakers filed an amicus brief in the Supreme Court on Monday to defend the country's leading consumer protection agency from challenges to its regulatory authority. Brown chairs the Senate Banking Committee while Waters is the ranking member of the House Financial Services Committee. The Supreme Court agreed to hear arguments in the case in February, four months after a federal appeals court panel unanimously ruled that the CFPB's funding method was unconstitutional. The Biden administration appealed the 5th Circuit's decision to the Supreme Court, but a final decision could be delayed until June 2024 to hear other arguments in the case. In the brief, lawmakers said succinctly that "the judgment should be reversed."

☆ Windfall tax seizure case in Michigan deepens appellate split on class standing issue
▼ + stars: | 2023-05-02 | by ( Alison Frankel | Thomson Reuters | Alison Frankel Has Covered High-Stakes Commercial Litigation As A Columnist For Reuters Since A Dartmouth College Graduate | ) www.reuters.com time to read: +6 min

The county auctioned Fox's property for about $25,000 — and kept the $22,000 difference between the sale price and Fox's tax obligation. But Fox’s class action did not name only Gratiot County as a defendant. Circuit Court disagreed. The 6th Circuit in the Fox case agreed with the 2nd Circuit's holding that trial courts must consider constitutional standing issues ahead of class certification. The Michigan counties that challenged class certification were represented at the 6th Circuit by Douglas Curlew of Cummings, McClorey, Davis & Acho.

Companies UBS Group AG FollowMay 1 (Reuters) - The U.S. Supreme Court on Monday agreed to examine how difficult it should be for financial whistleblowers to win retaliation lawsuits against their employers as the justices took up a long-running case involving Switzerland's UBS Group AG (UBSG.S). A Supreme Court ruling in favor of UBS could significantly curtail financial whistleblower lawsuits because it is often difficult for plaintiffs to prove a defendant's motives. Robert Herbst, a lawyer for Murray, said the 2nd Circuit decision ignored the text of the whistleblower law, adding that he looked forward to arguing the case before the Supreme Court. A UBS spokesperson said, "We expect the court will uphold the 2nd Circuit's decision." The Supreme Court is due to hear the case in its next term, which begins in October.

WASHINGTON, April 24(Reuters) - The U.S. Supreme Court on Monday declined to hear a challenge by computer scientist Stephen Thaler to the U.S. Patent and Trademark Office's refusal to issue patents for inventions his artificial intelligence system created. According to Thaler, his DABUS system, short for Device for the Autonomous Bootstrapping of Unified Sentience, created unique prototypes for a beverage holder and emergency light beacon entirely on its own. The U.S. Patent and Trademark Office and a federal judge in Virginia rejected his patent applications for the inventions on the grounds that DABUS is not a person. Thaler has also applied for DABUS patents in other countries including the United Kingdom, South Africa, Australia and Saudi Arabia with limited success. The UK's Supreme Court heard Thaler's appeal of his loss there in March.

HOW DID THE CASE GET TO THE SUPREME COURT? The Biden administration and Danco immediately asked the Supreme Court to overrule the 5th Circuit and impose an emergency stay. WHAT DID THE SUPREME COURT DO? The injunction was not at issue before the Supreme Court, and remains in effect. Once it does come, the losing side will again have the chance to appeal to the 5th Circuit and, eventually, the Supreme Court.

☆ Rippers roll in Adelaide as LIV lands Down Under
▼ + stars: | 2023-04-20 | by ( ) www.reuters.com time to read: +2 min

SYDNEY, April 20 (Reuters) - After falling short in their bid to gatecrash the Masters, the stars of LIV Golf break fresh ground in Adelaide this weekend when they take the rebel tour to Australia for the first time. The fourth of the 14 events on the schedule in the second season of LIV Golf was all but guaranteed a warm reception Down Under, despite concerns in some quarters that its Saudi backers are engaged in "sportswashing". "Obviously we're going there to win," said the 29-year-old world number six, who defected to LIV for a reported $140 million after his British Open triumph last year. Former world number one and twice major champion Martin Kaymer will make his return after six months on the sidelines recovering from a wrist injury as captain of "Cleeks". Having been pointedly excluded from Augusta, LIV Golf Commissioner Greg Norman has been ubiquitous in the media in his homeland this week promoting his product.

REUTERS/Brian Snyder/File PhotoWASHINGTON, April 17 (Reuters) - The U.S. Supreme Court on Monday declined to hear Novartis Pharmaceuticals Corp's (NOVN.S) bid to revive a key patent on its blockbuster multiple sclerosis drug Gilenya that was invalidated amid a legal dispute with China's HEC Pharm Co Ltd (1558.HK). Novartis sued HEC and more than a dozen other generic drugmakers for patent infringement in Delaware federal court after they applied for FDA approval of Gilenya generics. Novartis settled with some of the drugmakers, allowing for some Gilenya generics before a key patent's 2027 expiration. The Supreme Court in October rejected a Novartis emergency bid to pause the decision. HEC responded that the Federal Circuit "followed its own rules," and that "no Federal Circuit judge - including the dissenter - suggested any procedural concern" with the decision.

[1/2] The sun sets on the U.S. Supreme Court building after a stormy day in Washington, U.S., November 11, 2022. REUTERS/Leah MillisApril 14 (Reuters) - New court-imposed restrictions on the abortion pill mifepristone could cut off access to the drug entirely for months, the Biden administration and the drug's distributor, Danco Laboratories, said in petitions asking the U.S. Supreme Court to lift the curbs. Circuit Court of Appeals on Wednesday will require a new approval from the U.S. Food and Drug Administration and new labeling, they said. Danco, whose sole product is the abortion pill, said that if the Supreme Court does not act, it may have to halt its operations. Some Democratic-led states have said that they have taken steps to stockpile mifepristone in case it becomes unavailable.

An appeals court put part of that decision on hold late Wednesday, preserving access to the pill for now, with significant restrictions the Justice Department will ask the Supreme Court to lift. Neither Kacsmaryk's order, known as a preliminary injunction, nor the 5th Circuit's emergency stay is a final ruling on the merits of the case. REUTERS/Evelyn HocksteinThe Biden administration said on Thursday it will appeal to the Supreme Court for an emergency stay of Kacsmaryk's order in full. If the FDA wins a stay from the Supreme Court blocking the injunction, mifepristone will remain available with no new restrictions. Once it does come, the losing side will again have the chance to appeal to the 5th Circuit and, eventually, the Supreme Court.

☆ U.S. appeals court allows abortion pill mifepristone to stay on the market but blocks mail delivery
▼ + stars: | 2023-04-13 | by ( Spencer Kimball | ) www.cnbc.com time to read: +4 min

A federal appeals court has allowed the abortion pill mifepristone to remain on the U.S. market for now, but it imposed major restrictions on the medication that will significantly limit access. The order bars mail delivery of the abortion pill. "If allowed to stand, the consequences of this decision will be catastrophic not just for medication abortion access, but the entire drug approval system." The Alliance Defending Freedom, the anti-abortion group that sued the FDA, said the appeals court decision restores critical safeguards while the litigation proceeds. The order does not impact misoprostol, which is commonly used as a standalone abortion medication in other parts of the world.

April 11 (Reuters) - A U.S. appeals court handed Moderna Inc (MRNA.O) a win on Tuesday, affirming a decision to cancel an Arbutus Biopharma Corp (ABUS.O) patent related to the companies' legal fight over Moderna's blockbuster COVID-19 vaccines. The U.S. Court of Appeals for the Federal Circuit upheld a U.S. Patent and Trademark Office tribunal's ruling that the patent for Arbutus' lipid nanoparticle (LNP) technology was invalid based on an earlier Arbutus patent that disclosed the same invention. Moderna challenged the patent at the PTO's Patent Trial and Appeal Board in 2018, and the board invalidated it in 2019. Arbutus separately sued Pfizer and BioNTech for patent infringement last week over their COVID-19 shots, in a lawsuit that also does not include the canceled patent. The Federal Circuit case is Arbutus Biopharma Corp v. ModernaTX Inc, U.S. Court of Appeals for the Federal Circuit, No.

March 31 (Reuters) - Apple Inc (AAPL.O) on Friday convinced a U.S. appeals court to throw out a $502 million verdict for patent licensing company VirnetX Inc (VHC.N) in a long-running fight over internet privacy technology. The U.S. Court of Appeals for the Federal Circuit said the verdict could not stand after the U.S. Patent Trial and Appeal Board canceled the virtual private network (VPN) patents VirnetX accused Apple of infringing. The ruling follows the Federal Circuit's Thursday decision to affirm a U.S. Patent and Trademark Office tribunal's finding that the patents were invalid. Apple and VirnetX did not immediately respond to requests for comment. An East Texas jury awarded VirnetX $502 million in 2020 after finding Apple infringed the patents at issue in the Federal Circuit cases.

WASHINGTON, March 27 (Reuters) - Conservative U.S. Supreme Court justices on Monday appeared inclined to uphold a federal law that made it a crime to encourage illegal immigration, signaling agreement with President Joe Biden's administration that the measure does not violate constitutional free speech protections. Circuit Court of Appeals threw out Hansen's conviction for violating the provision, which bars inducing or encouraging noncitizens "to come to, enter or reside" in the United States illegally, including for financial gain. The 9th Circuit upheld Hansen's convictions on mail and wire fraud charges. The 9th Circuit decision applies in the group of western states over which it has jurisdiction including Arizona and California, which border Mexico. Circuit Court of Appeals, which has jurisdiction of a group of other states, also ruled against the law in a separate case.

☆ The fate of a post-2008 watchdog meant to protect Americans from another financial crisis is in the hands of a conservative Supreme Court
▼ + stars: | 2023-02-27 | by ( Ayelet Sheffey | Jason Lalljee | ) www.businessinsider.com time to read: +4 min

The Supreme Court will take on a lower court's decision that the Consumer Financial Protection Bureau's funding structure is unconstitutional. CFPB was set up to prevent another 2008-like financial crisis and has cracked down on big banks and the student-loan industry. On Monday, the Supreme Court agreed to take a decision from the Fifth Circuit Court of Appeals, which ruled in October that the Consumer Financial Protection Bureau's (CFPB) funding structure is unconstitutional. The Supreme Court won't hear the case until next term, though, meaning a final decision isn't likely until the spring of 2024. Created in 2011 under former President Barack Obama, the CFPB was intended to protect Americans from another financial crisis following the 2008 recession.

The justices will hear the case during the court's next term, which begins in October. The case is the latest to come before the Supreme Court seeking to rein in the authority of federal agencies. The CFPB, which enforces consumer financial laws, was created after the 2008 financial crisis as part of a federal law known as the Dodd–Frank Wall Street Reform and Consumer Protection Act. A Democratic-led Congress in 2010 set up the agency to draw funding annually from the Federal Reserve, the U.S. central bank, which last fiscal year transferred around $642 million to the consumer protection agency. The court heard arguments in November in two other cases involving agency power.

☆ Elizabeth Warren urges the Supreme Court to strike down Trump-appointed judges' decision to imperil funding for a student-loan industry and consumer-rights watchdog
▼ + stars: | 2023-02-27 | by ( Jason Lalljee | Ayelet Sheffey | ) www.businessinsider.com time to read: +5 min

The Supreme Court will take on a lower court's decision that the Consumer Financial Protection Bureau's federal funding is unconstitutional. Senator Elizabeth Warren advocated for the Supreme Court to strike down that decision. "If the Supreme Court follows more than a century of law and historical precedent, it will strike down the Fifth Circuit's decision before it throws our financial markets and economy into chaos." McHenry, who now runs the House Financial Services Committee, has hinted at seeking stronger oversight for CFPB for months now. And that's on top of a longer context of Republicans challenging the CFPB's funding and decision making.

☆ The Supreme Court lets police officers avoid being sued after they arrested an Ohio man for making fun of cops on Facebook
▼ + stars: | 2023-02-21 | by ( Grace Eliza Goodwin | Ashley Collman | ) www.businessinsider.com time to read: +5 min

The Supreme Court declined to take up his case, effectively allowing the police officers to avoid the lawsuit. Novak appealed that decision to the Supreme Court, even getting the satirical news site The Onion to write an amicus brief. The Supreme Court regularly takes on less than 1% of the case petitions it receives every year, according to News 5 Cleveland. In recent years there has been an effort in the US to end qualified immunity protections for police officers. The George Floyd Justice in Police Act was passed by the House in 2020 and included a section restricting qualified immunity for police officers.

Search resuls for: "Circuit's"

25 mentions found